Skip to main content
logo
Genmab A/S (GMAB)
NASDAQ: GMAB · Real-Time Price · USD
34.11
+1.15 (3.49%)
At close: Aug 19, 2026, 4:00 PM EDT
33.93
-0.18 (-0.53%)
Pre-market: Aug 20, 2026, 4:45 AM EDT

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20
DARZALEX Royalties Revenue
744.00M
Kesimpta Royalties Revenue
143.00M
TEPEZZA Royalties Revenue
31.00M
Other Product Royalties Revenue
48.00M
Total Royalties Revenue
966.00M
Net Product Sales
145.00M
Reimbursement Revenue
12.00M
Milestone Revenue
10.00M
Collaboration Revenue
22.00M
Revenue (Other)
-966.00M
Revenue (Total)
1.16B

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021Q2 2021Q1 2021Q4 2020Q3 2020
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21 Jun '21 Mar '21 Dec '20 Sep '20
J&J Revenue
783.00M
Roche Revenue
31.00M
Novartis Revenue
144.00M
BioNTech Revenue
4.00M
Pfizer Revenue
23.00M
Total Other Collaboration Partner Revenue
25.00M
Revenue (Total)
1.16B